CNCR

ETF Series Solutions Trust Range Cancer Therapeutics ETF

Delisted

CNCR was delisted on the 27th of May, 2025.

28 hedge funds and large institutions have $12.8M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2018 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$3.95M
2
$2.42M
3
$1.1M
4
$768K
5
$629K
6
$613K
7
$529K
8
$425K
9
$359K
10
$336K
11
$332K
12
$291K
13
$248K
14
$232K
15
$169K
16
$83K
17
$66.2K
18
$64K
19
$40K
20
$39K
21
$34K
22
$24K
23
$21K
24
$17K
25
$17K